Pilot Trial of Preoperative (Neoadjuvant) Letrozole in Combination With Bevacizumab in Postmenopausal Women With Newly Diagnosed Estrogen Receptor–or Progesterone Receptor–Positive Breast Cancer

INTRODUCTION: Tumor content or expression of vascular endothelial growth factor (VEGF) is associated with impaired efficacy of antiestrogen adjuvant therapy. We designed a pilot study to assess the feasibility and short-term efficacy of neoadjuvant letrozole and bevacizumab (anti-VEGF) in postmenopa...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Breast Cancer
Hlavní autoři: Forero-Torres, Andres, Saleh, Mansoor N., Galleshaw, Janice A., Jones, Cheryl F., Shah, Jatin J., Percent, Ivor J., Nabell, Lisle M., Carpenter, John T., Falkson, Carla I., Krontiras, Helen, Urist, Marshall M., Bland, Kirby I., De Los Santos, Jennifer F., Meredith, Ruby F., Caterinicchia, Valerie, Bernreuter, Wanda K., O'Malley, Janis P., Li, Yufeng, LoBuglio, Albert F.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4451110/
https://ncbi.nlm.nih.gov/pubmed/20705559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3816/CBC.2010.n.035
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky